Circulating Microparticles Decrease After Cardiac Stress in Patients With Significant Coronary Artery Stenosis

Clinical Cardiology

Volumn 39, Issue 10, 2016, Pages 570-577

  Sinning, Jan Malte ^a   Jansen, Felix ^a   Hammerstingl, Christoph ^a   Meier, Arne ^a   Losch, Jan ^a   Rohwer, Katharina ^a   Schmitz, Theresa ^a   Paul, Kathrin ^a   Sedaghat, Alexander ^a   Schueler, Robert ^a   Vasa Nicotera, Mariuca ^a   Müller, Cornelius ^a   Nickenig, Georg ^a   Werner, Nikos ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD14 ANTIGEN; CD16 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MATRIX METALLOPROTEINASE; PHOSPHATIDYLSERINE; VASCULAR ENDOTHELIAL CADHERIN; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; LEUKOCYTE ANTIGEN; PHOSPHATIDYLSERINE RECEPTOR;

AGED; ARTICLE; CELL FUNCTION; CENTRIFUGATION; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY OBSTRUCTION; ECHOCARDIOGRAPH; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETER; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART STRESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MONOCYTE; PRACTICE GUIDELINE; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; STRESS ECHOCARDIOGRAPHY; THROMBOCYTE; BLOOD; DIAGNOSTIC IMAGING; KINETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

AGED; ANTIGENS, CD; BIOMARKERS; CELL-DERIVED MICROPARTICLES; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; ECHOCARDIOGRAPHY, STRESS; ENDOTHELIAL CELLS; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX;

EID: 84992665624     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22566     Document Type: Article

References (33)

1. Loyer X, Vion AC, Tedgui A, et al. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res. 2014;114:345–353.
2. Amabile N, Boulanger CM. Circulating microparticle levels in patients with coronary artery disease: a new indicator of vulnerability? Eur Heart J. 2011;32:1958–1960.
3. Rautou PE, Vion AC, Amabile N, et al. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011;109:593–606.
4. Horstman LL, Jy W, Jimenez JJ, et al. New horizons in the analysis of circulating cell-derived microparticles. Keio J Med. 2004;53:210–230. http://doi.org/10.2302/kjm.53.210.
5. Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005;45:1622–1630.
6. Nozaki T, Sugiyama S, Sugamura K, et al. Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail. 2010;12:1223–1228.
7. Werner N, Wassmann S, Ahlers P, et al. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2006;26:112–116.
8. Amabile N, Cheng S, Renard JM, et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J. 2014;35:2972–2979.
9. Sinning JM, Losch J, Walenta K, et al. Circulating CD31+/annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32:2034–2041.
10. Augustine D, Ayers LV, Lima E, et al. Dynamic release and clearance of circulating microparticles during cardiac stress. Circ Res. 2014;114:109–113.
11. Williams BM, Williams JC. Dobutamine stress-induced microparticle release: a sign of health? Circ Res. 2014;114:15–17.
12. Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008;9:415–437.
13. Windecker S, Kolh P, Alfonso F, et al; Authors/Task Force Members. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS): developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–2619.
14. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:99–1007.
15. Jansen F, Yang X, Hoelscher M, et al. Endothelial microparticle–mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation. 2013;128:2026–2038.
16. Wahl P, Jansen F, Achtzehn S, et al. Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors. PLoS One. 2014;9:e96024.
17. Jansen F, Yang X, Baumann K, et al. Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism. J Cell Mol Med. 2015;19:2202–2214.
18. Jansen F, Yang X, Hoyer FF, et al. Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis. Arterioscler Thromb Vasc Biol. 2012;32:1925–1935.
19. Jansen F, Yang X, Franklin BS, et al. High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. Cardiovasc Res. 2013;98:94–106.
20. Hoyer FF, Giesen MK, Franca C, et al. Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. J Cell Mol Med. 2012;16:2777–2788.
21. Rautou PE, Leroyer AS, Ramkhelawon B, et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1–dependent monocyte adhesion and transendothelial migration. Circ Res. 2011;108:335–343.
22. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010;107:1047–1057.
23. Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res. 2011;108:1284–1297.
24. Abid Hussein MN, Nieuwland R, Hau CM, et al. Cell-derived microparticles contain caspase 3 in vitro and in vivo. J Thromb Haemost. 2005;3:888–896.
25. Galloway MT, Paglieroni TG, Wun T, et al. Platelet activation during dobutamine stress echocardiography. Am Heart J. 1998;135(5 part 1):888–900.
26. Dasgupta SK, Abdel-Monem H, Niravath P, et al. Lactadherin and clearance of platelet-derived microvesicles. Blood. 2009;113:1332–1339.
27. Davila M, Amirkhosravi A, Coll E, et al. Tissue factor–bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost. 2008;6:1517–1524.
28. Dasgupta SK, Le A, Chavakis T, et al. Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation. 2012;125:1664–1672.
29. Willekens FL, Werre JM, Kruijt JK, et al. Liver Kupffer cells rapidly remove red blood cell–derived vesicles from the circulation by scavenger receptors. Blood. 2005;105:2141–2145.
30. Al Faraj A, Gazeau F, Wilhelm C, et al. Endothelial cell–derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice. Radiology. 2012;263:169–178.
31. Setty BNY, Betal SG. Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes. Blood. 2008;111:905–914.
32. De Rosa S, Fichtlscherer S, Lehmann R, et al. Transcoronary concentration gradients of circulating microRNAs. Circulation. 2011;124:1936–1944.
33. Lacroix R, Robert S, Poncelet P, et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative Workshop. J Thromb Haemost. 2010;8:2571–2574.